Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors

Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors

US Patent 9017660 · Granted Apr 28, 2015

Estimated economic value: $11,959,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of a canine CD20 positive disease or condition using a canine CD20-spe2025
Compositions and methods for lyophilization of bacteria or listeria strains2025
Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated pr2024
Compositions and methods comprising KLK3 or FOLH1 antigen2022
Compositions and methods comprising KLK3 or FOLH1 antigen2022
Compositions and methods for lyophilization of bacteria or listeria strains2021
Treatment of a canine CD20 positive disease or condition using a canine CD20-spe2021
Compositions comprising angiogenic factors and methods of use thereof2020
Compositions comprising angiogenic factors and methods of use thereof2020
Compositions comprising angiogenic factors and methods of use thereof2020
Methods for constructing antibiotic resistance free vaccines2019
Recombinant Listeria vaccine strains and methods of producing the same2019